Is Your Practice’s Retirement Plan at Risk?
Mandell is an attorney and founder of the wealth management firm OJM Group in Cincinnati, Ohio. Braunscheidel is a wealth adviser at OJM Group.
Cleaning Up Cleanser Misinformation
In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, explains misinformation surrounding skin and hair cleansing.
Sidestep Traps That Lead to Misdiagnosis
Dermatologist urges colleagues to take mindful measures to avoid errors.
How an Honest Mistake Can Lead to Fraud
In this month's Legal Eagle column, David J. Goldberg, MD, JD, discusses coding and billing in physician practices.
Combination Approaches Drive Cosmeceutical Regimens
Natural skincare ingredients are always trending, said Patricia K. Farris, MD, hear what she had to say about using these in combination with other regimens.
If Approved, Cantharidin 0.7% Could be Standard of Molluscum Care
Cantharidin 0.7% could be an emerging standard for molluscum treatment.
Comments Offer Perspectives on Coppertone Recall
Coppertone, David Light, founder and CEO of Valisure, and Christopher Bunick, MD, PhD, share their thoughts on the sunscreen giant’s voluntary recall of 12 lots of its aerosol sunscreen after finding the presence of benzene.
Master the Clues that Mask Malignancy
Case-based observations offered clinicians real-world guidance on distinguishing underlying malignancies in the Therapeutic Hotline session at Maui Derm NP+PA Fall 2021.
Pediatric Acne: What Signs are Concerning?
Which is more worrisome, neonatal or infantile acne? An expert answered this question and more during Maui Derm NP+PA Fall 2021’s update on acne and rosacea.
Management of Scarring Alopecia
In his presentation at Maui Derm NP+PA Fall 2021, Jerry Shapiro, MD, FAAD, shared his treatment protocols for lupus erythematosus, lichen planopilaris, folliculitis decalvans, and dissecting cellulitis.
Using Combination Therapies and Avoiding Subtypes for Rosacea
In this presentation on rosacea from Maui Derm NP+PA Fall 2021, Julie Harper, MD, explains why combination therapy is more effective and how classifying rosacea patients by subtype can lead to suboptimal treatments.
Psoriasis Updates: Comparing IL-23 and IL-17 Inhibitors, TNF Blockers
Factors include extent of disease, the latest findings on agents’ efficacy, and even patient weight.
AK Overview: Current Guidelines and Emerging Therapies
A review of the American Academy of Dermatology guidelines and current treatment improvements for actinic keratosis were discussed during a presentation at Maui Derm NP+PA Fall 2021.
Pipeline of Promise for Atopic Dermatitis
New therapies raise patient expectations for fast efficacy, lower costs, and fewer adverse effects.
New Frontiers in Laser, Light, Optical Devices
Innovations include underserved populations, acne, and advanced applications.
